 | Up a level |
Achtnichts, L; Chan, A; Czaplinski, A; Derfuss, T; Du Pasquier, R; Findling, O; Gobbi, C; Hoepner, R; Kamber, N; Kamm, C P; Kuhle, J; Lalive, P; Lutterotti, A; Martin, R; Müller, S; Papadopoulou, A; Pot, C; Salmen, A; Schippling, S and Zecca, C (2019). Specific aspects of immunotherapy for multiple sclerosis in Switzerland: A structured commentary. Clinical and translational neuroscience, 3(1), 2514183X1882207. Sage Publications 10.1177/2514183X18822073
Schoepfer, A M; Schaffer, T; Seibold-Schmid, B; Müller, S; Seibold, F (2008). Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients. Neurogastroenterology and motility, 20(10), pp. 1110-8. Oxford: Blackwell Science 10.1111/j.1365-2982.2008.01166.x
Müller, S; Oevermann, A; Wenker, C; Altermatt, H J; Robert, Nadia (2007). A mixed epithelial and stromal tumor of the kidney in a ringtail lemur (Lemur catta). Veterinary pathology, 44(2), pp. 243-6. Middleton, Wis.: American College of Veterinary Pathologists 10.1354/vp.44-2-243
Schaffer, T; Müller, S; Seibold, F (2006). Mechanisms of anti-Saccharomyces cerevisiae antibody development in Crohn's Disease. Schweizerisches Medizin-Forum SMF / Swiss medical forum / Forum médical suisse FMS, 6:(Suppl 33) Basel: EMH Editores Medicorum Helveticorum
Müller, S; Lory, J; Corazza, N; Griffiths, G M; Z'graggen, K; Mazzucchelli, L; Kappeler, A; Müller, C (1998). Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease. American journal of pathology, 152(1), pp. 261-268. Elsevier
Hunger, R E; Müller, S; Laissue, J A; Hess, M W; Carnaud, C; Garcia, I; Mueller, C (1996). Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. Journal of clinical investigation, 98(4), pp. 954-961. American Society for Clinical Investigation 10.1172/JCI118879
